Main Menu

Many African countries, including Nigeria, Tanzania, Kenya, Uganda, and Cameroon, have community-based health insurance schemes that provide protection for the poor but are unsustainable because poor people cannot contribute enough premiums to keep the programmes running.

The One Africa One People Foundation (OAOP) launched the African Health Initiative in 2023 to strengthen health systems in West Africa by supporting partnerships and large-scale models of care that link implementation research and workforce training directly to the delivery of integrated primary healthcare.

Global healthcare has never seen a period like this one. The pandemic’s ramifications have resulted in a paradigm shift that has challenged the existing design and functioning of health systems and has expedited the need for the establishment of creative ecosystems with overhauled health delivery models and scaling capacities.

Governments in Africa, as in the rest of the globe, are investing heavily on healthcare to meet the global healthcare problem. These budgets are becoming increasingly unsustainable, making the change to digital technology a critical step in redefining healthcare professional (HCP)-patient connections and supporting a new era of care access for the continent’s population.

Public-Private Partnerships (PPPs) in health are spreading across Africa as governments recognise the critical role of the private sector in delivering and sustaining health services and bridging the continent’s numerous gaps.
However, for this new paradigm for providing public health and healthcare delivery systems to succeed, a number of solid factors must be considered, including a strong political commitment and institutional support, a coherent integration into each national health strategy, favourable fiscal conditions, agreed PPP policies, and a clear regulatory framework.

The One Africa One People Foundation Initiative will advocate for African pharmaceutical manufacturing. Telemedicine will be adopted throughout West Africa, allowing more remote health care personnel to conduct face-to-face appointments.

Pharmaceutical Manufacturing in Africa is Being Localised

The COVID-19 epidemic has highlighted African countries’ reliance on global pharmaceutical markets and imports of key medicines and healthcare items. In order to mitigate the severe impact of disrupted global supply chains and strengthen domestic pharmaceutical manufacturing capabilities, governments in these markets have been forced to renew their attention on pharmaceutical localisation activities.

In addition to localised manufacturing, the pharmaceutical sector is pursuing localization through partnerships and joint ventures with local enterprises, an initiative strongly supported by local governments.
These initiatives lay the groundwork for long-term localisation ambitions, as well as create legislation and policies that will shape the region’s pharmaceutical and healthcare sector.

Telemedicine foundations will be created for broader adoption throughout the West Africa.

Telemedicine had arisen as an alternative to filling the gap in Africa’s poor health resources and infrastructure long before the COVID-19 disaster. The present pandemic crisis has heightened this demand, as more than 400 million people currently lack access to healthcare.
While a few African countries have previously established telemedicine policies and guidelines, most countries still face regulatory, delivery model, internet connectivity, and human resource difficulties.

Governments and insurance players must also explore win-win reimbursement methods that allow for the democratisation of telemedicine while also providing long-term benefits to patients at a reasonable cost.

Face-to-face and remote detailing to Healthcare Professionals will be used.

With access restrictions in place to help combat the spread of COVID-19, all pharma and life sciences companies shifted to remote detailing within the first few months of the pandemic, allowing them to stay connected with healthcare professionals during this critical period.
Today, with medical promotional activity returning to normal, virtual detailing remains popular among HCPs due to the ability to receive information when and where it is convenient, while also assisting life sciences companies in increasing their capacity to engage with HCPs confidently and compliantly.